Governor Deval Patrick joined the Massachusetts Life Sciences Center and ARGO Medical Technologies at the AdvaMed 2012 conference in Boston today to announce that Israeli-founded exoskeleton technology leader, ARGO, has selected Massachusetts as its U.S. headquarters.
â€śMassachusetts is a global leader in the life sciences industry because of our strong investment in education and innovation,â€ť said Gov. Patrick, who led a trade mission to Israel last spring to further strengthen ties between the innovation industries in Massachusetts and Israel. â€śI am pleased to welcome ARGO and their remarkable technology to Massachusetts, and I look forward to the continued growth of their company as they bring new jobs into the Commonwealth.â€ť
ARGO Medical Technologiesâ€™ product, the ReWalk, is an exoskeleton suit that enables persons with lower limb disabilities, such as paraplegia, to stand and walk independently without assistance. The companyâ€™s founder, Dr. Amit Goffer, is a person with quadriplegia who was inspired to invent the exoskeleton device because of his own personal story. ARGO was founded in Israel, but has grown internationally. Along with its Massachusetts headquarters, it now has centers in Germany and Israel. The new Massachusetts headquarters, which the company expects to house up to 40 employees, will be located in Marlborough.
â€śAs ARGO expands from a research and development firm to an international leader in commercial exoskeleton technology, we have selected Massachusetts with its strong commitment to the life sciences industry as our U.S. headquarters,â€ť said Larry Jasinski, CEO of ARGO Medical Technologies. â€śThe ReWalk is a cutting-edge device that will revolutionize the mobility industry, and we are committed to making this technology commercially available to anyone who wants one here in the U.S. and around the world.â€ť
Through the Massachusetts Life Sciences Center, Massachusetts is investing $1 billion over ten years in the growth of the stateâ€™s life sciences supercluster. These investments are being made under the Massachusetts Life Sciences Initiative, proposed by Gov. Patrick in 2007, and passed by the State Legislature and signed into law by Gov. Patrick in 2008.
â€śARGOâ€™s technology is truly life-changing,â€ť said Susan Windham-Bannister, Ph.D., President & CEO of the Massachusetts Life Sciences Center, the agency charged with implementing Gov. Patrickâ€™s Life Sciences Initiative. â€śMillions of people with neurodegenerative diseases and spinal cord injuries, including many of our returning veterans, have been waiting for this kind of breakthrough technology. We are proud to welcome ARGO to the Massachusetts life sciences community.â€ť
â€śWe are excited to welcome ARGO to the strong and growing medical technology community here in Massachusetts,â€ť said Tom Sommer, President of MassMEDIC, the Massachusetts Medical Device Industry Council. â€śWith more than 400 medical device companies located in the Commonwealth, a supportive state government and a world-class workforce, ARGO will undoubtedly find the resources it needs here to put the ReWalk into the homes of patients across the U.S.â€ť
At the press conference, U.S. Army Veteran Theresa Hannigan demonstrated the ReWalk exoskeleton technology.Â Hannigan is a former Army Sergeant, who served during the Vietnam era and was left paralyzed two years ago as a result of a progressive autoimmune disease that she contracted while in the Army. Hannigan has been training with the ReWalk at the National Center of Excellence for the Medical Consequences of Spinal Cord Injury at the James J. Peters V.A. Medical Center in Bronx, New York, and is planning to use the exoskeleton on October 20, 2012 to walk a one-mile road race in Lindenhurst, New York, to raise money for the organization â€śHope for the Warriors,â€ť which helps U.S. service men and women.
â€śI am very excited for the day I can take the ReWalk home to use in my daily life,â€ť said Hannigan. â€śItâ€™s the simple things that I miss that I canâ€™t do in my wheelchair. When Iâ€™m sitting on the couch, it is difficult and time-consuming to transition into my wheelchair for a simple task, like getting a glass of water. With the ReWalk, I can just stand up, walk in to the kitchen, get a glass in the cabinet and pour it for myself.â€ť
The ReWalk is currently available in the U.S. at rehabilitation centers and is awaiting FDA clearance for personal use. In Europe, it is also being used in rehabilitation facilities, and ARGO has recently announced the ReWalkâ€™s commercial availability to take home for personal use throughout the European Union.
About ARGO Medical Technologies
ARGO Medical TechnologiesÂ develops, manufactures and markets walk restoration devices for people with lower limb disabilities. The company'sÂ ReWalkâ„˘ exoskeleton allows an ambulation and rehabilitation alternative to wheelchair users, enabling people with lower limb disabilities, such as paraplegia, to stand and walk independently. ARGO is operated by a team of experts in the fields of rehab devices, control and computer sciences with decades of combined experience in R&D, engineering and manufacturing of multidisciplinary systems. The company is assisted by renowned international experts in the fields of medicine, biomedical engineering, robotics and marketing. Founded in 2001 in Israel, ARGO is today an international company with headquarters in the US, Germany and Israel. For more information, please visit http://www.argomedtec.com/.
About the Massachusetts Life Sciences Center
The Massachusetts Life Sciences Center (â€śthe Centerâ€ť) is a quasi-public agency of the Commonwealth of Massachusetts tasked with implementing the Massachusetts Life Sciences Act, a ten-year, $1 billion initiative that was signed into law in June of 2008. The Centerâ€™s mission is to create jobs in the life sciences and support vital scientific research that will improve the human condition. This work includes making financial investments in public and private institutions that are advancing life sciences research, development and commercialization as well as building ties among sectors of the Massachusetts life sciences community. For more information, visit www.masslifesciences.com.Business Wire
Last updated on: 02/10/2012